Prevention of Metastasis by Suppression of Stemness Genes Using a Combination of microRNAs

Area of Science:

• Oncology
• Molecular Biology
• Biotechnology

Background:

• Cancer metastasis involves the dedifferentiation of cancer cells in metastatic niches, leading to stemness gene activation.
• Blocking this dedifferentiation is a potential strategy for preventing secondary tumor growth.

Purpose of the Study:

• To investigate a novel microRNA combination therapy for preventing cancer metastasis.
• To evaluate the efficacy of a specific microRNA mixture in blocking cancer cell dedifferentiation and stemness.

Main Methods:

• Transcriptome microarray analysis to identify gene expression patterns in human breast cancer cell lines treated with a microRNA mixture.
• In vitro mammosphere formation assays using differentiated CD44- cancer cells.
• In vivo evaluation of the microRNA mixture encapsulated in lipid nanoparticles in a mouse model of spontaneous metastasis.

Main Results:

• The microRNA mixture downregulated stemness genes, inhibiting cancer cell dedifferentiation.
• Treatment with the microRNA mixture significantly reduced mammosphere formation in vitro.
• Encapsulated microRNA combination therapy effectively prevented lung metastasis in a mouse model.

Conclusions:

• A combination of miR-195-5p, miR-520a, and miR-630 holds significant therapeutic potential for metastasis prevention.
• This antimetastatic strategy effectively blocks tumor cell dedifferentiation, crucial for micrometastasis to macrometastasis transition.